Anagenics LimitedASX: AN1

Market Update

· Issued by Anagenics Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Anagenics Limited has announced a restructuring update regarding the sale of its Face MediGroup business to its co-founders, which will allow the company to exit this segment and reduce operating costs. The transaction involves the assumption of liabilities and cancellation of a deferred payment obligation, with no cash exchanged at settlement.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Anagenics Limited on 6ix

Earlier from Anagenics

Later from Anagenics

All Anagenics news releases